Status:
UNKNOWN
Malic Acid in Treatment of Xerostomia
Lead Sponsor:
Hams Hamed Abdelrahman
Conditions:
Xerostomia
Eligibility:
All Genders
35-50 years
Phase:
NA
Brief Summary
Background: xerostomia is a subjective sensation of dry mouth resulting from quantitative and /or qualitative changes of saliva. Patients receiving drugs like antihypertensives and antidepressants or ...
Detailed Description
This randomized controlled clinical trial included 52 patients with type 2 diabetes mellitus suffering from xerostomia, divided equally into two groups. Group-I was managed by topical spray containing...
Eligibility Criteria
Inclusion
- Patients with type 2 diabetes mellitus suffering from xerostomia.
- Patients aged between 35 and 50 years old.
- Glycated hemoglobin less than 7% (28) .
- Duration of diabetes mellitus not less than 4 years and not more than 8 years.
Exclusion
- Patients receiving any drugs that cause hyposalivation like anti-hypertensive drugs.
- Patients with any systemic disease reported to produce hyposalivation (sjogren's syndrome, hepatitis c, rheumatoid arthritis and lupus erythematosus) (8).
- Patients receiving chemo-therapy and radio-therapy.
- Mouth breathers.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04756986
Start Date
January 1 2021
End Date
November 1 2021
Last Update
February 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry, Alexandria University
Alexandria, Egypt